Therefore, these PD1+ tumor infiltrating lymphocytes (TILs) in ICC patients with HBV infection probably have lost their T cell function and maybe act as a marker for assaying tumor response of PD1 inhibitor 11. This evidence concerns the gene PDCD1 and intrahepatic cholangiocarcinoma.